News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
363,280 Results
Type
Article (17500)
Company Profile (105)
Press Release (345675)
Section
Business (107102)
Career Advice (506)
Deals (19730)
Drug Delivery (55)
Drug Development (39159)
Employer Resources (58)
FDA (9377)
Job Trends (8797)
News (178136)
Policy (15790)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1470)
Academic (1)
Adcomms (6)
Allergies (44)
Alliances (30326)
ALS (52)
Alzheimer's disease (865)
Antibody-drug conjugate (ADC) (58)
Approvals (9429)
Artificial intelligence (145)
Autoimmune disease (6)
Automation (10)
Bankruptcy (108)
Best Places to Work (7303)
BIOSECURE Act (11)
Biosimilars (55)
Biotechnology (57)
Bladder cancer (31)
Brain cancer (12)
Breast cancer (144)
Cancer (1075)
Cardiovascular disease (86)
Career advice (450)
Career pathing (8)
CAR-T (68)
Cell therapy (205)
Cervical cancer (8)
Clinical research (32615)
Collaboration (542)
Compensation (180)
Complete response letters (8)
COVID-19 (1616)
CRISPR (20)
C-suite (122)
Cystic fibrosis (44)
Data (1129)
Denatured (14)
Depression (22)
Diabetes (120)
Diagnostics (4863)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (16)
Drug discovery (59)
Drug pricing (22)
Drug shortages (11)
Duchenne muscular dystrophy (30)
Earnings (36813)
Editorial (15)
Employer branding (11)
Employer resources (51)
Events (56488)
Executive appointments (425)
FDA (9998)
Featured Employer (28)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (356)
Gene editing (49)
Generative AI (14)
Gene therapy (169)
GLP-1 (355)
Government (2100)
Grass and pollen (3)
Guidances (29)
Healthcare (10024)
Huntington's disease (5)
IgA nephropathy (16)
Immunology and inflammation (44)
Indications (21)
Infectious disease (1703)
Inflammatory bowel disease (81)
Inflation Reduction Act (1)
Influenza (31)
Intellectual property (47)
Interviews (62)
IPO (8697)
IRA (12)
Job creations (1892)
Job search strategy (417)
Kidney cancer (6)
Labor market (4)
Layoffs (185)
Leadership (5)
Legal (2868)
Liver cancer (39)
Lung cancer (184)
Lymphoma (72)
Machine learning (2)
Management (15)
Manufacturing (178)
MASH (33)
Medical device (7614)
Medtech (7619)
Mergers & acquisitions (11367)
Metabolic disorders (293)
Multiple sclerosis (42)
NASH (12)
Neurodegenerative disease (39)
Neuropsychiatric disorders (10)
Neuroscience (1134)
NextGen: Class of 2025 (2801)
Non-profit (2299)
Northern California (1228)
Now hiring (20)
Obesity (152)
Opinion (73)
Ovarian cancer (25)
Pain (39)
Pancreatic cancer (36)
Parkinson's disease (73)
Partnered (10)
Patents (76)
Patient recruitment (53)
Peanut (29)
People (33843)
Pharmaceutical (36)
Pharmacy benefit managers (1)
Phase I (8569)
Phase II (13437)
Phase III (13055)
Pipeline (521)
Podcasts (21)
Policy (37)
Postmarket research (1309)
Preclinical (3193)
Press Release (61)
Prostate cancer (47)
Psychedelics (15)
Radiopharmaceuticals (161)
Rare diseases (177)
Real estate (4148)
Recruiting (22)
Regulatory (11913)
Reports (19)
Research institute (1496)
Resumes & cover letters (59)
Rett syndrome (2)
RSV (22)
Schizophrenia (42)
Series A (70)
Series B (46)
Service/supplier (4)
Sickle cell disease (31)
Southern California (1072)
Special edition (3)
Sponsored (20)
Startups (1752)
State (1)
Stomach cancer (6)
Supply chain (41)
The Weekly (7)
United States (11273)
Vaccines (379)
Venture capitalists (13)
Webinars (8)
Weight loss (88)
Women's health (15)
Worklife (1)
Date
Today (126)
Last 7 days (564)
Last 30 days (1847)
Last 365 days (21176)
2025 (3491)
2024 (21499)
2023 (23967)
2022 (33555)
2021 (36124)
2020 (34167)
2019 (25937)
2018 (19617)
2017 (18152)
2016 (17517)
2015 (19975)
2014 (14799)
2013 (12130)
2012 (13099)
2011 (12920)
2010 (11379)
Location
Africa (393)
Alabama (20)
Alaska (5)
Arizona (82)
Arkansas (7)
Asia (25754)
Australia (4298)
California (2787)
Canada (945)
China (344)
Colorado (117)
Connecticut (112)
Delaware (82)
Europe (55614)
Florida (419)
Georgia (99)
Hawaii (1)
Idaho (29)
Illinois (242)
India (20)
Indiana (212)
Iowa (3)
Japan (109)
Kansas (42)
Kentucky (10)
Louisiana (3)
Maine (30)
Maryland (396)
Massachusetts (2207)
Michigan (156)
Minnesota (178)
Mississippi (1)
Missouri (51)
Montana (20)
Nebraska (9)
Nevada (24)
New Hampshire (49)
New Jersey (1021)
New Mexico (16)
New York (903)
North Carolina (548)
North Dakota (6)
Northern California (1228)
Ohio (134)
Oklahoma (7)
Oregon (10)
Pennsylvania (656)
Puerto Rico (5)
Rhode Island (15)
South America (625)
South Carolina (5)
Southern California (1072)
Tennessee (47)
Texas (421)
Utah (93)
Virginia (62)
Washington D.C. (25)
Washington State (262)
West Virginia (1)
Wisconsin (26)
363,280 Results for "acm global central laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Actimed Therapeutics Announces Publication of Successful S-pindolol benzoate (ACM-001.1) Phase 1 Study in The Journal of Cachexia, Sarcopenia and Muscle
December 13, 2024
·
3 min read
Bio NC
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
Labcorp announced today the launch of Labcorp Global Trial Connect, a suite of central laboratory solutions aimed at increasing the speed of clinical trials where the heart of clinical research is conducted – investigator sites.
June 17, 2024
·
2 min read
Press Releases
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
November 19, 2024
·
8 min read
Press Releases
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
August 7, 2024
·
4 min read
Drug Development
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, announced positive topline results from a Phase I trial of ACM-001, the Company’s first clinical-stage development program.
September 5, 2023
·
4 min read
Press Releases
Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services
November 13, 2024
·
2 min read
Deals
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has announced the expansion of its neurology portfolio with the acquisition of 11 central nervous system brands from global healthcare company, Sanofi.
September 18, 2023
·
4 min read
Press Releases
Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
September 4, 2024
·
3 min read
Press Releases
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central America
January 15, 2025
·
6 min read
Press Releases
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
January 14, 2025
·
6 min read
1 of 36,328
Next
